EQL Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:7JK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Nov 24	Sell€142,842	FÅRö Capital Ab	Company	26,000	€5.49
03 Oct 24	Buy€24,701	Martin Kristofferson	Individual	5,000	€4.94
24 May 24	Buy€219,453	Axel Schorling	Individual	53,903	€4.07
24 May 24	Buy€219,453	Axel Schorling	Individual	53,903	€4.07
12 Dec 23	Sell€877,371	FÅRö Capital Ab	Company	300,000	€2.92

Insider Buying: 7JK insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 14 shareholders own 68.51% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30%	Cadila Pharmaceuticals Limited	8,718,500	€50.3m	0%	no data
27.9%	FÅRö Capital Ab	8,101,348	€46.8m	-0.32%	98.13%
4.33%	SEB Investment Management AB	1,258,398	€7.3m	0%	0.01%
1.51%	Carnegie Fonder AB	440,251	€2.5m	0%	0.04%
1.07%	Axel Schorling	311,016	€1.8m	0%	no data
1.06%	Cliens Kapitalförvaltning AB	306,928	€1.8m	0%	0.06%
0.88%	Alexander Brising	256,543	€1.5m	0%	no data
0.86%	Schroder Investment Management Limited	250,000	€1.4m	0%	no data
0.73%	Amundi Asset Management SAS	213,260	€1.2m	-5.3%	no data
0.07%	Martin Kristofferson	20,200	€116.6k	32.9%	no data
0.047%	Anna Jonsson	13,729	€79.3k	0%	no data
0.034%	Anders Mansson	10,000	€57.7k	0%	no data
0.034%	Per Svangren	10,000	€57.7k	0%	no data
0.0086%	Linda Neckmar	2,500	€14.4k	0%	no data